using a combination of a clonogenic tumor cell assay , an hpc culture assay , and a mixed-tumor-cell-hpc culture assay , selective elimination of more than 98 % of clonogenic neoplastic cells from tumor-cell-contaminated bone marrow suspensions was achieved with monoclonal anti-dq antibodies and complement without depletion of hpc .
C0597032
neoplastic cells
C0027651
tumor